{"id":"NCT01727700","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","briefTitle":"Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder","officialTitle":"A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Fixed-Dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-11","primaryCompletion":"2013-08","completion":"2013-09","firstPosted":"2012-11-16","resultsPosted":"2015-02-13","lastUpdate":"2015-02-13"},"enrollment":133,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Tourette's Disorder","Tic Disorder"],"interventions":[{"type":"DRUG","name":"Aripiprazole","otherNames":["Abilify"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Aripiprazole 5 mg or 10 mg","type":"EXPERIMENTAL"},{"label":"Aripiprazole 10 mg or 20 mg","type":"EXPERIMENTAL"}],"summary":"The goal of the current trial is to determine efficacy and safety of Once-daily aripiprazole in reducing Total Tic Severity in children and adolescents with Tourette's Disorder.","primaryOutcome":{"measure":"Change From Baseline to Week 8 in Yale Global Tic Severity Scale (YGTSS) Total Tic Score (TTS).","timeFrame":"Baseline to Week 8","effectByArm":[{"arm":"Aripiprazole Low Dose","deltaMin":-13.35,"sd":1.59},{"arm":"Aripiprazole High Dose","deltaMin":-16.94,"sd":1.61},{"arm":"Placebo","deltaMin":-7.09,"sd":1.55}],"pValues":[{"comp":"OG000 vs OG002","p":"0.0020"},{"comp":"OG001 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"7 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":21},"locations":{"siteCount":75,"countries":["United States","Canada","Germany","Hungary","Italy","Mexico","Romania","Spain","Sweden"]},"refs":{"pmids":["28686474"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":44},"commonTop":["Sedation","Somnolence","Fatigue","Nausea","Increased appetite"]}}